Zerapeutics AB is a Swedish research and development company in the field of biological drug development, based in Gothenburg. Zerapeutics aims to drive projects from idea to clinical trial through strategic collaborations and financing.
Impact: Working towards a future with better healthcare for cancer treatments.
Founders: Lisa & Jonas Nilsson
GUV Contact: Lorna Fletcher
